Position in HLN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$9,330
New position
Shares Held
1,000
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#483
of 639 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bay Harbor Wealth Management, LLC holds $63,968 across 13 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,000 | $33,880 | |
| 2 | HLN |
Haleon plc
This page
|
1,000 | $9,330 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11 | $5,960 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
31 | $5,224 | |
| 5 | VTRS |
Viatris Inc
|
228 | $3,620 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91 | $2,239 | |
| 7 | ALKS |
Alkermes plc.
|
23 | $1,205 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
9 | $998 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,330 | 1,000 | Shares | Other | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||